Issue 26, 2021

Co-delivery of proteins and small molecule drugs for mitochondria-targeted combination therapy

Abstract

Herein, we report the first use of gluthathione (GSH)-responsive nanogel-based carriers for mitochondria-targeted delivery of functional proteins and antibodies. We further demonstrated the successful co-encapsulation of a protein and small molecule (RNase A/Doxorubicin) in dual-cargo nanocapsules for mitochondria-targeted combination therapy.

Graphical abstract: Co-delivery of proteins and small molecule drugs for mitochondria-targeted combination therapy

Supplementary files

Article information

Article type
Communication
Submitted
10 Dec 2020
Accepted
18 Feb 2021
First published
18 Feb 2021

Chem. Commun., 2021,57, 3215-3218

Co-delivery of proteins and small molecule drugs for mitochondria-targeted combination therapy

S. S. Liew, J. Zhou, L. Li and S. Q. Yao, Chem. Commun., 2021, 57, 3215 DOI: 10.1039/D0CC08020A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements